Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 2.73M | P/E | - | EPS this Y | 37.00% | Ern Qtrly Grth | - |
| Income | -29.93M | Forward P/E | -6.20 | EPS next Y | 23.50% | 50D Avg Chg | -72.00% |
| Sales | 785k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -96.00% |
| Dividend | N/A | Price/Book | 0.19 | EPS next 5Y | - | 52W High Chg | -98.00% |
| Recommedations | 3.00 | Quick Ratio | 1.01 | Shares Outstanding | 4.90M | 52W Low Chg | 123.00% |
| Insider Own | 0.10% | ROA | -32.74% | Shares Float | 4.57M | Beta | 2.97 |
| Inst Own | 7.24% | ROE | -74.36% | Shares Shorted/Prior | 370.18K/195.73K | Price | 0.56 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 509,004 | Target Price | 21.00 |
| Oper. Margin | -4,016.82% | Earnings Date | May 10 | Volume | 1,155,058 | Change | 0.00% |
About Zosano Pharma Corporation
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Matthews Christine | Chief Financial Offi.. Chief Financial Officer | Jun 06 | Sell | 0.71 | 82 | 58 | 4,183 | 06/07/22 |
| Lo Steven | Chief Executive Offi.. Chief Executive Officer | Jun 06 | Sell | 0.71 | 442 | 314 | 13,163 | 06/07/22 |
| Matthews Christine | Chief Financial Offi.. Chief Financial Officer | Mar 31 | Sell | 0.2101 | 8,116 | 1,705 | 146,425 | 04/01/22 |
| KELLERMAN DONALD J | VP, Clinical Dev & M.. VP, Clinical Dev & Med Affairs | Mar 31 | Sell | 0.2101 | 4,006 | 842 | 56,331 | 04/01/22 |
| Lo Steven | Chief Executive Offi.. Chief Executive Officer | Mar 31 | Sell | 0.2101 | 23,633 | 4,965 | 460,709 | 04/01/22 |